Indo US Bio-Tech (NSE:INDOUS) Total Current Liabilities: ₹395 Mil (As of Mar. 2026)


NSE:INDOUS Indo US Bio-Tech Ltd NSE:INDOUS
63 GF Score
Price ₹87.52
GF Value ₹312.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Indo US Bio-Tech Total Current Liabilities?

Indo US Bio-Tech NSE:INDOUS -2.29% 63 Total Current Liabilities is ₹395 Mil as of Mar. 2026. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹312.39 (Possible Value Trap). The stock has 5 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Indo US Bio-Tech's total current liabilities for the quarter that ended in Mar. 2026 was ₹395

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Indo US Bio-Tech Total Current Liabilities Related Terms

Indo US Bio-Tech Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Indo US Bio-Tech's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo US Bio-Tech Total Current Liabilities Chart

Indo US Bio-Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 122.84 122.93 188.63 163.39 395.23

Indo US Bio-Tech Quarterly Data
Mar20 Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 163.39 0.00 290.89 0.00 395.23
NSE:INDOUS
63GF Score
Indo US Bio-Tech Ltd NSE:INDOUS
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo US Bio-Tech Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Indo US Bio-Tech's Total Current Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=8.907+360.836
+Other Current Liabilities+Current Deferred Liabilities
=25.482+0
=395

Indo US Bio-Tech's Total Current Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=8.907+360.836
+Other Current Liabilities+Current Deferred Liabilities
=25.482+0
=395

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of ₹395 Mil mean?
Indo US Bio-Tech (NSE:INDOUS) has a Total Current Liabilities of ₹395 Mil as of Mar. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Indo US Bio-Tech and its competitors.
Is Indo US Bio-Tech's Total Current Liabilities too high?
Indo US Bio-Tech's current Total Current Liabilities is ₹395 Mil. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Total Current Liabilities compare to CTVA and CF?
Indo US Bio-Tech's Total Current Liabilities of ₹395 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for an Agriculture company?
A good Total Current Liabilities depends on the Agriculture industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Indo US Bio-Tech and its competitors. Indo US Bio-Tech's current Total Current Liabilities is ₹395 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹312.39, compared to a current price of ₹87.52 — trading 72% below its estimated fair value. The current Total Current Liabilities is ₹395 Mil. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current Total Current Liabilities is ₹395 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?

Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued. The current stock price of ₹87.52 is trading 72% below its estimated GF Value™ of ₹312.39. GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.

Key valuation signals for NSE:INDOUS:

  • Total Current Liabilities: ₹395 Mil
  • GF Value™: ₹312.39 vs. price of ₹87.52 (72% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indo US Bio-Tech Business Description

Other Exchanges 541304:India
Address Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score

Get the complete analysis for NSE:INDOUS

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹87.52
Price
₹312.39
GF Value